Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Eli Lilly & Company Foundation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$46M
Portfolio companies 13
Rounds per year 0.25
Lead investments 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Biopharma
  • Health Care
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Eli Lilly & Company Foundation:
Typical Co-investors
Eli Lilly & Company Foundation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Eli Lilly & Company Foundation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Batshit Crazy Ventures Boulder, Colorado, United States
BlueGem Capital Partners England, London, United Kingdom
Cossette Canada, Quebec, Quebec
Cowtown Angels Fort Worth, Texas, United States
Crystal Internet Venture Funds Cleveland, Ohio, United States
CureDuchenne Ventures -
Fung Shing Investments -
Hongrui Touzi China, Jiading, Shanghai
Inner Mongolia Kenuohuagai Investment Management -
KNT-CT Holdings Japan, Tokyo
Link11 Frankfurt, Germany, Hessen
Panorama Point Partners Nebraska, Omaha, United States
Sesame Workshop New York, New York, United States
Soilbuild Group Holdings Central, Central Region, Singapore
Taixiang Investment Management China, Ningbo, Zhejiang
Yifeng Investment China, Shanghai
ZenPharma Limited -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Zephyr AI

Biotechnology
$111M13 Mar 2024 Fairfax Station, Virginia, United States

Mediar Therapeutics

Biotechnology
Therapeutics
$85M15 Mar 2023 Cambridge, Massachusetts, United States

Switch Therapeutics

Biotechnology
Medical
Therapeutics
$52M14 Mar 2023 San Francisco, California, United States

PrescriberPoint

Health Care
31 Jan 2023 Boston, Massachusetts, United States

SonoThera

Biopharma
Biotechnology
Genetics
Medical
$60M05 Dec 2022 San Francisco, California, United States

Strand Therapeutics

Biotechnology
Therapeutics
$45M28 Nov 2022 Cambridge, Massachusetts, United States

Capstan Therapeutics

Biotechnology
Health Care
Therapeutics
$102M14 Sep 2022 San Diego, California, United States

Photys Therapeutics

Biotechnology
$75M08 Sep 2022 Cambridge, Massachusetts, United States

TRex Bio

Bioinformatics
Biopharma
Biotechnology
$26M08 Mar 2022 South San Francisco, California, United States
News
MiNA Therapeutics Receives $15M Equity Investment from Eli Lilly and Company

– MiNA Therapeutics Limited is a London, UK-based provider of small activating RNA therapeutics.
– Company received $15m equity investment from Eli Lilly and Company.
– The funds will be used to advance and expand its internal pipeline of saRNA therapeutics.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Eli Lilly & Company Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 46M
Rounds per year 0.25
Peak activity year 2022
Lead investments 3
Group Appearance index 0.79

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Zephyr AI

Biotechnology
$111M13 Mar 2024 Fairfax Station, Virginia, United States

Mediar Therapeutics

Biotechnology
Therapeutics
$85M15 Mar 2023 Cambridge, Massachusetts, United States

Switch Therapeutics

Biotechnology
Medical
Therapeutics
$52M14 Mar 2023 San Francisco, California, United States

PrescriberPoint

Health Care
31 Jan 2023 Boston, Massachusetts, United States

SonoThera

Biopharma
Biotechnology
Genetics
Medical
$60M05 Dec 2022 San Francisco, California, United States

Strand Therapeutics

Biotechnology
Therapeutics
$45M28 Nov 2022 Cambridge, Massachusetts, United States

Capstan Therapeutics

Biotechnology
Health Care
Therapeutics
$102M14 Sep 2022 San Diego, California, United States

Photys Therapeutics

Biotechnology
$75M08 Sep 2022 Cambridge, Massachusetts, United States

TRex Bio

Bioinformatics
Biopharma
Biotechnology
$26M08 Mar 2022 South San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: